City
Epaper

Experimental vaccine for swine fever virus shows promise

By IANS | Updated: January 26, 2020 13:10 IST

Researchers have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines.

Open in App

Currently, there is no commercially available vaccine against African swine fever, which has been devastating the swine industry in Eastern Europe and Southeast Asia.

African swine fever virus (ASFV) is highly contagious and often lethal to domestic and wild pigs, according to the the study, published in the Journal of Virology.

"This new experimental ASFV vaccine shows promise, and offers complete protection against the current strain currently producing outbreaks throughout Eastern Europe and Asia," said study researcher Douglas P Gladue from Plum Island Animal Disease Center, Agricultural Research Service, US Department of Agriculture.

The research was motivated by the 2007 outbreak of African swine fever in the Republic of Georgia.

"This was the first outbreak in recent history outside of Africa and Sardiniawhere swine fever is endemicand this particular strain has been highly lethal and highly contagious, spreading quickly to neighboring countries," Gladue said.

"This is also a new strain of the virus, now known as ASFV-G (the G stands for Georgia)," Gladue added.

For the findings, researchers set out to develop a vaccine. Part of the process of developing whole virus vaccines involves deleting virulence genes from the virus.

But when the researchers deleted genes similar to those that had been deleted in older ASFV strains to attenuate them, "it became clear that ASFV-G was much more virulent" than the other, historical isolates, because it retained a higher level of virulence, said Gladue.

The researchers then realised they needed a different genetic target in order to attenuate ASFV-G.

They used a predictive methodology called a computational pipeline to predict the roles of proteins on the virus. The computational pipeline predicted that a protein called I177l could interfere with the immune system of the pig.

When they deleted this gene, ASFV-G was completely attenuated.

In the study, both low and high doses of the vaccine were 100 per cent effective against the virus when the pigs were challenged 28 days post-inoculation, the researchers said.

( With inputs from IANS )

Tags: AfricaEastern EuropeGeorgia
Open in App

Related Stories

InternationalRare Total Solar Eclipse to Darken Skies Over Europe, Africa & Middle East on August 2, 2027

InternationalAtlanta: 5 Injured in Boat Explosion on Lake Lanier in Georgia (Watch Video)

InternationalGeorgia: 12 Indian Nationals Found Dead in Restaurant from Carbon Monoxide Poisoning

Navi MumbaiIndia-Africa Trade Centre in Kharghar to Enhance Bilateral Relations

Navi MumbaiNavi Mumbai: African National Arrested with Cocaine Worth Rs 1.02 Crore in Ulwe

स्वास्थ्य Realted Stories

HealthOver 18,900 organ transplants in 2024, highest in a single year: JP Nadda

HealthDiabetic patient can return to normal blood sugar levels without medication: PGI Chandigarh

HealthStates asked to undertake regular screening to tackle rising fatty liver disease: Nadda

HealthPGIMER Chandigarh gets Best ROTTO Award for second consecutive year

HealthSevere malnourishment in children under five years old can spike antibiotic resistance: Study